Evidence for an active transport of morphine-6-β-D-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier
Evidence for an active transport of morphine-6-β-D-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier
复制标题
DOI:
10.1046/j.1471-4159.2003.01990.x
复制
发表时间:
2003-09-01
影响因子:
4.7
通讯作者:
Scherrmann, JM
中科院分区:
文献类型:
--
作者:
Bourasset, F;Cisternino, S;Scherrmann, JM
Morphine-6-beta-D-glucuronide (M6G) is an active metabolite of morphine with high analgesic potency despite a low blood-brain barrier (BBB) permeability. The aim of the study was to elucidate its transport mechanism across the BBB. We first checked if M6G was effluxed by the P-glycoprotein (P-gp), as previously reported by others. Second, we investigated the role of anionic transporters like the multidrug resistance-associated protein mrp1 and the glucose transporter GLUT-1. The brain uptake of [C-14]M6G was measured by the in situ brain perfusion technique in wild-type and deficient mice [mdr1a(-/-) and mrp1(-/-)], with and without probenecid, digoxin, PSC833 or D-glucose. No difference was found between P-gp and mrp1 competent and deficient mice. The brain uptake of [C-14]M6G co-perfused with probenecid in wild-type mice was not significantly different from that found in group perfused with [C-14]M6G alone. The co-perfusion of [C-14]M6G with digoxin or PSC833 was responsible of a threefold decrease of its uptake in mdr1a competent and deficient mice, suggesting that another transporter than P-gp and sensitive to digoxin and PSC833, may be involved. The co-perfusion of [C-14]M6G with D-glucose revealed a threefold decrease in M6G uptake. In conclusion, P-gp and mrp1 are not involved in the transport of M6G at the BBB level in contrast to GLUT-1 and a digoxin-sensitive transporter (probably oatp2), which can actively transport M6G but with a weak capacity.